Dobroslav Melamed
Founder presso CANNABOTECH LTD
Patrimonio netto: - $ in data 31/03/2024
Profilo
Dobroslav Melamed is the founder of Cannabotech Ltd.
(2019) and Peri-Ness Technologies Ltd.
Dr. Melamed is currently the Independent Non-Executive Director at XTL Biopharmaceuticals Ltd.
(since 2014), President & Director at Insight Biopharmaceuticals Ltd., Director at Venture Rif Capital Ltd., Director & Chief Technology Officer at Trioxmed Ltd., Trioxebo Ltd., and Trioxnano Ltd.
Dr. Melamed's former position includes being the President of SciVac Ltd.
Dr. Melamed's education includes undergraduate, graduate, and doctorate degrees from Bar-Ilan University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
22/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Dobroslav Melamed
Società | Posizione | Inizio |
---|---|---|
XTL BIOPHARMACEUTICALS LTD. | Director/Board Member | 08/12/2014 |
CANNABOTECH LTD | Founder | 02/01/2019 |
Venture Rif Capital Ltd. | Director/Board Member | - |
Trioxmed Ltd. | Chief Tech/Sci/R&D Officer | - |
Trioxebo Ltd. | Chief Tech/Sci/R&D Officer | - |
Insight Biopharmaceuticals Ltd.
Insight Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Insight Biopharmaceuticals Ltd. is an Israeli company that manufactures and commercializes biosimilars and new antibody therapeutics. The private company is based in Rehovot, Israel. | President | - |
Trioxnano Ltd. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Dobroslav Melamed
Società | Posizione | Fine |
---|---|---|
SciVac Ltd.
SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | President | 01/09/2014 |
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Founder | - |
Formazione di Dobroslav Melamed
Bar-Ilan University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
XTL BIOPHARMACEUTICALS LTD. | Health Technology |
CANNABOTECH LTD | Health Technology |
Aziende private | 7 |
---|---|
Peri-Ness Technologies Ltd.
Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Health Technology |
Insight Biopharmaceuticals Ltd.
Insight Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Insight Biopharmaceuticals Ltd. is an Israeli company that manufactures and commercializes biosimilars and new antibody therapeutics. The private company is based in Rehovot, Israel. | Health Technology |
SciVac Ltd.
SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The private company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Health Technology |
Venture Rif Capital Ltd. | |
Trioxmed Ltd. | |
Trioxebo Ltd. | |
Trioxnano Ltd. |
- Borsa valori
- Insiders
- Dobroslav Melamed